Left ventricular effects of nicorandil in comparison with nitroglycerin in chronic conscious dogs
Tóm tắt
Nicorandil is a new coronary vasodilator possessing beneficial properties. However, its detailed cardiovascular effects, especially on left ventricular (LV) preload, have not yet been fully elucidated. The purpose of this study was to assess the effects of nicorandil on LV hemodynamics in conscious dogs and to examine the mechanisms of its anti-ischemic action. Nine mongrel dogs were instrumented for instantaneous and continuous measurements of LV diameters, and aortic and LV pressures. The effects of nicorandil (0.2 mg/kg, intravenously) were compared with those of nitroglycerin (15 μg/kg, intravenously) in conscious dogs. Mean aortic pressure decreased similarly with both nicorandil and nitroglycerin (−20.1±3.1% vs. 21.6±2.8%, ns). Heart rate was elevated with both drugs. Both nicorandil and nitroglycerin significantly decreased LV systolic pressure to the same extent (−11.3±0.5% vs.−10.5±11.6^, ns). LV max dp/dt was not significantly changed by either drug. Although both nicorandil and nitroglylerin significantly increased fractional shortening, nicorandil had a greater effect on fractional shortening than nitroglycerin (20.0±3.0% vs. 10.2±2.3%, p<0.05). In this study, nicorandil, administered intravenously, had a salutary effect on cardiac function. LV enddiastolic diameter decreased with nicorandil and nitroglycerin (−6.5±1.5% vs.−12.6±2.6%, p<0.01), respectively. In conclusion, nicorandil decreased LV end-diastolic diameter in conscious dogs, indicating a decrease in venous return and preload of the heart. In addition, nicorandil decreased LV afterload to the same extent as nitroglycerin. The decrease in preload and afterload on the heart is thought to be one of the mechanisms of the antiischemic action of nicorandil.
Tài liệu tham khảo
Nakagawa Y, Takeda K, Katano Y, et al. Effect of 2-nicotinamidoethyl nitrate on the cardiovascular system.Jpn Heart J 1979;20:881–895.
Taira N, Satoh K, Yanagisawa T, et al. Pharmacological profile of a new coronary vasodilator drug, 2-nicotinamidoethyl nitrate (SG-75).Clin Exp Pharmacol Physiol 1979; 6:301–306.
Sakanashi M, Yoshikawa Y, et al. Effects of 2-nicotinamidoethy nitrate (SG-75) on cardiac function and myocardial metabolism of the dog.Pharmacometrics 1978;15:385–389.
Kinoshita M, Nishikawa N, Sawamura M, et al. Comparative efficacy of high-dose versus low-dose nicorandil therapy for chronic stable angina pectoris.Am J Cardiol 1986;58: 733–738.
Thormann J, Schlepper M, Kramer M, et al. Effectiveness of nicorandil (SG-75), a new long-acting drug with nitroglycerin effects, in patients with coronary artery disease: Improved left ventricular function and regional wall motion and abolition of pacing-induced angina.J Cardiovasc Pharmacol 1983;5:371–377.
Winbury M, Howe B, Hefner A. Effect of nitrates and other coronary dilators on large and small coronary vessels: A hypothesis for the mechanism of action of nitrates.J Pharmacol Exp Ther 1969;168:70–95.
Vatner SF, Pagani M, Manders WT. Alpha adrenergic vasoconstriction and nitroglycerin vasodilation of large coronary arteries in conscious dogs.J. Clin Invest 1980;65:5–14.
Mason DT, Braunwald E. The effect of nitroglycerin and amyl nitrate on arterial and venous tone in the human forearm.Circulation 1965;32:755–766.
Mason DT, Zelis R, Amsterdam EA. Actions of the nitrates on the peripheral circulation and myocardial oxygen consumption: Significance in the relief of angina pectoris.Chest 1971;59:296–305.
Hintze TH, Vatner SF. Comparison of effects of nifedipine and nitroglycerin on large and small coronary arteries and cardiac function, in conscious dogs.Circ Res 1983;52(Suppl 1): 139–146.
Goodman CC, Castellana FS. A digital sonomicrometer for two-point length and velocity measurements.Am J Physiol 1982;243:H634-H639.
Gobel FL. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris.Circulation 1978;57:549.
Sakanashi M, Noguchi K, Kato T. Vasodilating effects of nicorandil and nitroglycerin in anesthetized open-chest dogs.Naunyn-Schmiedeberg's Arch Pharmacol 1986;333: 439–444.
Vatner SF, Franklin D, Braunwald E. Effect of anesthesia and sleep on circulation response to carotid sinus nerve stimulation.Am J Physiol 1971;220:1249.
Vatner SF, Braunwald E. Cardiovascular control. Mechanisms in the conscious state.N Engl J Med 1975;293:970–976.
Braunwald E. Mechanisms governing contraction of the whole heart. In: Braunwald E, Ross J Jr, Sonnenblick EH, eds.Mechanisms of contraction of the normal and failing heart. Boston: Little Brown, 1976:92–129.
Braunwald E, Ross J Jr. The ventricular end-diastolic pressure.Am J Med 1963;34:147–150.
Yamada A, Tomoike H, Nakamura M, et al. Effect of nicorandil on large epicardial coronary artery in conscious dogs.Arznein Forsch Drug Res 1987;11:1252–1255.
Lamping KA, Gross GJ. Comparative effects of a new nicotinamide nitrate derivative, nicorandil (SG-75), with nifedipine and nitroglycerin on true collateral blood flow following acute coronary occlusion in dogs.J Cardiovasc Pharmacol 1984;6:601–608.
Lamping KA, Wartier DC, Gross GJ, et al. Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model.J Pharmacol Exp Ther 1984;229:359–363.
Tsuneyoshi H, Saitoh T, Ohno M, et al. Effects of nicorandil on various vessles of dogs.J Jpn Coll Angiol 1986;26: 539–544.
Mackenzie JE, Parratt JR. Comparative effects of glyceryl trinitrate on venous and arterial smooth muscle in vitro; relevance to antianginal activity.Br J Pharmacol 1977; 60:155–160.
Belz GG, Matthews J, Wagner G, et al. Controlled comparison of the pharmacodynamic effects of nicorandil (SG-75) and isosorbide dinitrate in man.Eur J Clin Pharmacol 1984;26:681–685.
Ishizaki T, Chiba K, Suganuma T, et al. Pharmacokinetics of nicorandil, a new coronary vasodilator in dogs.J Pharm Sci 1984;73:494–498.
Sakai K, Shiraki Y, Nabata H. Cardiovascular effects of a new coronary vasodilator n-(2-hydroxyethyl) nicotinamide nitrate (SG-75); comparison with nitroglycerin and diltiazem.J Cardiovasc Pharmacol 1981;3:139–150.
Kambara H, Nakamura Y, Kawai C, et al. Beneficial effects of nicorandil on cardiovascular hemodynamics.J Cardiovasc Pharmacol 1987;10:s104-s108.
Shimshak TM Preuss KC, Gross GJ, et al. Recovery of contractile function in post-ischemic reperfused myocardium of conscious dogs: Influence of nicorandil, a new antianginal agent.Cardiovasc Res 1986;20:621–626.